Notably, the IFN-γ + BMSCs + QSFZYL group exhibited superior tumor suppression compared to the IFN-γ + BMSCs group on days 8, 10, and 12 (P< 0.05) and to the BMSCs group on days 8 and 10 (P< 0.05). This evidence concerns the gene IFNG and neoplasm.